HCA Healthcare (NYSE:HCA) Given Neutral Rating at JPMorgan Chase & Co.

HCA Healthcare (NYSE:HCA - Get Free Report)'s stock had its "neutral" rating reissued by research analysts at JPMorgan Chase & Co. in a report released on Tuesday, Marketbeat.com reports. They currently have a $380.00 price target on the stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 23.48% from the stock's current price.

Other equities research analysts have also recently issued reports about the company. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Wells Fargo & Company cut HCA Healthcare from an "equal weight" rating to an "underweight" rating and lowered their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Cantor Fitzgerald reissued an "overweight" rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Tuesday, October 1st. Raymond James cut HCA Healthcare from an "outperform" rating to a "market perform" rating in a research note on Friday, November 22nd. Finally, Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a research report on Monday, August 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $385.63.

HCA Healthcare Price Performance

Shares of HCA traded down $1.86 during mid-day trading on Tuesday, reaching $307.74. The company had a trading volume of 1,633,540 shares, compared to its average volume of 1,208,194. The company's 50-day moving average is $353.88 and its 200-day moving average is $358.57. HCA Healthcare has a twelve month low of $263.22 and a twelve month high of $417.14. The company has a market capitalization of $77.95 billion, a P/E ratio of 13.81, a P/E/G ratio of 1.21 and a beta of 1.63. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

Insider Transactions at HCA Healthcare

In related news, insider Erol R. Akdamar sold 2,900 shares of the firm's stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company's stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares of the company's stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Institutional Investors Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of the stock. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the 2nd quarter worth $28,000. Legacy Investment Solutions LLC purchased a new stake in HCA Healthcare in the 3rd quarter valued at about $39,000. Capital Performance Advisors LLP purchased a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $41,000. Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the second quarter worth $33,000. Finally, Canoe Financial LP purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $41,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.